The molecular structure of human erythropoietin
- PMID: 7852212
The molecular structure of human erythropoietin
Abstract
The molecular structure of EPO has been discussed, and the gradual emergence of information about EPO has been reviewed. The importance of certain regions of the molecule and of glycosylation to EPO's structure and function are clear. Although its nucleotide and amino acid sequences are known, its tertiary structure remains elusive. Antipeptide antibody and mutagenesis studies have increased our ability to study structure/function and certain spatial relationships. Undoubtedly, additional information will continue to become available in this exciting area, providing a better understanding of the mechanisms behind EPO's central role in erythropoiesis.
Similar articles
-
Recombinant human erythropoietin (rHuEPO): cross-linking with disuccinimidyl esters and identification of the interfacing domains in EPO.Protein Sci. 1993 Sep;2(9):1441-51. doi: 10.1002/pro.5560020908. Protein Sci. 1993. PMID: 8401229 Free PMC article.
-
Erythropoietin and erythropoiesis stimulating agents.Drug Test Anal. 2012 Nov;4(11):805-12. doi: 10.1002/dta.1341. Epub 2012 Apr 16. Drug Test Anal. 2012. PMID: 22508651 Review.
-
Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1.Biochemistry. 1998 Mar 17;37(11):3699-710. doi: 10.1021/bi971956y. Biochemistry. 1998. PMID: 9521688
-
Erythropoietin and engineered innate repair activators.Methods Mol Biol. 2013;982:1-11. doi: 10.1007/978-1-62703-308-4_1. Methods Mol Biol. 2013. PMID: 23456859
-
Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response.J Intern Med. 2008 Nov;264(5):405-32. doi: 10.1111/j.1365-2796.2008.02024.x. J Intern Med. 2008. PMID: 19017170 Review.
Cited by
-
How bio-questionable are the different recombinant human erythropoietin copy products in Thailand?Pharm Res. 2014 May;31(5):1210-8. doi: 10.1007/s11095-013-1243-9. Epub 2013 Nov 21. Pharm Res. 2014. PMID: 24258097
-
Erythropoietin and cancer: the unintended consequences of anemia correction.Front Immunol. 2014 Nov 11;5:563. doi: 10.3389/fimmu.2014.00563. eCollection 2014. Front Immunol. 2014. PMID: 25426117 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials